Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Aytu Bioscience Inc (AYTUD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 16,669
  • Shares Outstanding, K 4,220
  • Annual Sales, $ 3,220 K
  • Annual Income, $ -22,510 K
  • 36-Month Beta 5.21
  • Price/Sales 4.98
  • Price/Cash Flow N/A
  • Price/Book 0.85
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -48.16
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/06/17
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.3400 +22.75%
on 08/28/17
4.5000 -8.89%
on 09/14/17
-0.2000 (-4.65%)
since 08/25/17
3-Month
3.3400 +22.75%
on 08/28/17
12.0000 -65.83%
on 07/28/17
-7.6000 (-64.96%)
since 06/27/17
52-Week
3.3400 +22.75%
on 08/28/17
77.8000 -94.73%
on 10/04/16
-62.9000 (-93.88%)
since 09/27/16

Most Recent Stories

More News
Aytu BioScience Announces Commercial Availability of Tuzistra(R) XR (codeine polistirex and chlorpheniramine polistirex) oral suspension

AYTUD : 4.1000 (+3.80%)
AYTU : 0.91 (+1.11%)
Aytu BioScience Provides Webcast Information for 2018 LD Micro Conference Presentation

Live Webcast at 9:00 am PT/12:00 pm ET Wednesday, December 5, 2018

AYTUD : 4.1000 (+3.80%)
AYTU : 0.91 (+1.11%)
Aytu BioScience Announces Appointment of Two New Directors, Steven Boyd and Ketan Mehta

ENGLEWOOD, CO / ACCESSWIRE / December 3, 2018 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products addressing significant medical...

AYTUD : 4.1000 (+3.80%)
AYTU : 0.91 (+1.11%)
Aytu BioScience Announces Closing of $5M Investment from Armistice Capital

Strategic Investment Positions Company with Approximately $19M in Cash

AYTUD : 4.1000 (+3.80%)
AYTU : 0.91 (+1.11%)
Investor Expectations to Drive Momentum within ANGI Homeservices, Aytu Bioscience, IRIDEX, Cellular Biomedicine Group, CounterPath, and EXFO -- Discovering Underlying Factors of Influence

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of ANGI Homeservices Inc. (NASDAQ:ANGI),...

ANGI : 16.23 (-1.87%)
AYTUD : 4.1000 (+3.80%)
CBMG : 19.23 (-0.36%)
AYTU : 0.91 (+1.11%)
IRIX : 4.17 (+0.48%)
CPAH : 1.41 (-1.40%)
EXFO : 2.78 (+0.36%)
Aytu BioScience to Report Interim Results from Natesto(R) Spermatogenesis Study on Thursday, November 15, 2018

Live Conference Call and Webcast Scheduled for 5:00 p.m. ET on November 15, 2018 Presentation of Interim Analysis by Dr. Ranjith Ramasamy, MD, Director of Reproductive Urology and Assistant Professor,...

AYTUD : 4.1000 (+3.80%)
AYTU : 0.91 (+1.11%)
Aytu BioScience Reports 55% Sequential Revenue Growth in Q1 FY19; Adds Tuzistra(R) XR to Portfolio

AYTUD : 4.1000 (+3.80%)
AYTU : 0.91 (+1.11%)
Aytu BioScience to Report Fiscal First Quarter 2019 Results and Business Update

Live Conference Call and Webcast Scheduled for November 7, 2018, at 4:30 p.m. ET

AYTUD : 4.1000 (+3.80%)
AYTU : 0.91 (+1.11%)
New Age Beverages Corporation Appoints Gregory A. Gould as Chief Financial and Administrative Officer

DENVER, CO / ACCESSWIRE / October 12, 2018 / NEW AGE BEVERAGES CORPORATION (NASDAQ: NBEV), the Colorado-based organic, natural and healthy functional beverage company focused on becoming the world's leading...

NBEV : 6.44 (+8.42%)
CYDY : 0.5200 (+1.96%)
MHMNF : 54.5000 (unch)
AYTUD : 4.1000 (+3.80%)
ATRX : 0.3100 (unch)
AMPE : 0.43 (+7.50%)
Aytu BioScience Announces Issuance of First U.S. Patent Covering MiOXSYS(R) for Male Infertility; Company Progresses Toward U.S. Regulatory Clearance and Commercialization

U.S. Patent Number 10,088,466 is Company's First United States Patent Covering MiOXSYS for Male Infertility Assessment

AYTUD : 4.1000 (+3.80%)
AYTU : 0.91 (+1.11%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade AYTUD with:

Key Turning Points

2nd Resistance Point 4.2200
1st Resistance Point 4.1600
Last Price 4.1000
1st Support Level 4.0200
2nd Support Level 3.9400

See More

52-Week High 77.8000
Fibonacci 61.8% 49.3563
Fibonacci 50% 40.5700
Fibonacci 38.2% 31.7837
Last Price 4.1000
52-Week Low 3.3400

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar